World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. It should be a warning to other pharma companies. Now Biogen is a shell of a company selling off assets to survive.

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

World of DTC Marketing

JANUARY 4, 2022

In 2014, cancer patients paid $4 billion out-of-pocket for cancer treatment. These cost estimates include cancer-attributable costs for medical services and oral prescription drugs. Pharma companies are aware that insurers will rarely say no to new cancer therapies, but increased scrutinization of early approvals is on the horizon.

Insurance 273

Insurance Transportation Medical Medicine 273

pharmaphorum

DECEMBER 15, 2022

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. ” The post Pharma says VPAS clawback jeopardises UK sector appeared first on. The increase to 26.5% VPAS tax on top. .”

Pharma 72

Pharma Government Manufacturing Medicine 72

Pharma Leaders

MAY 30, 2023

Italy-based Abiogen Pharma has announced the acquisition of a 97.09% stake in Switzerland-based EffRx Pharmaceuticals. Abiogen Pharma’s business spans across many integrated aspects : research and development, manufacturing of pharmaceuticals under its own brand or third-party contracts, and marketing of its own and licensed drugs.

Pharmaceutical 52

Pharmaceutical Pharma Distribution Prescription 52

pharmaphorum

NOVEMBER 14, 2022

A study of public tenders for prescription medicines between 2014 and 2019 shows a fall in multi-criteria tenders rewarding “environmental” attributes and an average weighting of only 5% (see Figure 2). This way, we can ensure that every person, as well as every fraction of a degree, will matter in the decades to come.

Medicine 105

Medicine Pharmaceutical Healthcare Healthcare 105

Clarivate

MAY 13, 2024

Insurance exchanges underwent their largest single-year enrollment growth since their inception in 2014, pushing exchange enrollment to yet another all-time high. Reconnection to coverage is also variable by state, with some states forcing families to re-apply for coverage, a process that can take weeks.

Insurance 52

Insurance Marketing Healthcare Healthcare 52

pharmaphorum

SEPTEMBER 30, 2022

The approval makes Relyvrio (sodium phenylbutyrate and taurursodiol) the first new therapy option for ALS – also known as motor neuron disease (MND) – since Mitsubishi Tanabe Pharma’s intravenous Radicava (edaravone) was cleared by the FDA in 2017. An oral version of edaravone was cleared this year. The organisation contributed $2.2

FDA 98

FDA Doctors Patients Prescription 98